Drug pricing: Further legal action launched against US government’s price negotiations

More drug companies and organisations are launching legal action over the US government’s plan to negotiate the prices of 10 expensive drugs.1Bristol Myers Squibb, the US Chamber of Commerce, the National Infusion Center Association, the Global Colon Cancer Association, and the pharmaceutical lobbying group Pharmaceutical Research and Manufacturers Association (PhRMA) sued Xavier Becerra, head of the US Department of Health and Human Services, and Chiquita Brooks-LaSure, head of the Centers for Medicare and Medicaid Services, on 23 June.1They claim that the Inflation Reduction Act passed in 2022 unconstitutionally violates their rights under the first, fifth, and eighth amendments to the Constitution. Earlier this month Merck was first to sue the government on similar grounds.2US drug prices are among the highest in the world but negotiated prices were forbidden until passage of the act. The act allows the US government to negotiate prices for 10 expensive drugs used by patients who…
Read Original Article: Drug pricing: Further legal action launched against US government’s price negotiations »